Sensory demyelinating polyneuropathology as a manifestation of paraneoplastic encephalomyelitis associated to adenocarcinoma of the prostate;Polineuropatía sensitiva desmielinizante como manifestación de encefalomielitis paraneoplásica asociada al adenocarcinoma de próstata

Revista de Neurologia

Volumn 36, Issue 2, 2003, Pages 118-121

  Luengo Marquez C ^a   Gallego Moreno, J A ^a   Laguía Almansa, Lorenzo ^a,b   Martin Sebastia E ^a   Abizanda Soler, P ^a   Romero Rizos, L ^a  

^a Universitario de Albacete   (Spain)

^b NONE   (Spain)

Author keywords

Adenocarcinoma of the prostate; Neurological paraneoplastic syndrome; Sensory demyelinating polyneuropathology

Indexed keywords

AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CASE REPORT; CENTRAL NERVOUS SYSTEM METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; DEMYELINATING NEUROPATHY; ELECTROMYOGRAPHY; ENCEPHALOMYELITIS; HUMAN; IMMUNOPATHOLOGY; MALE; PARANEOPLASTIC SYNDROME; POLYNEUROPATHY; PROSTATE ADENOCARCINOMA; SENSORY NEUROPATHY; ADENOCARCINOMA; FATALITY; METASTASIS; PARANEOPLASTIC NEUROPATHY; PATHOLOGY; PROSTATE TUMOR; SYNDROME;

ADENOCARCINOMA; AGED; FATAL OUTCOME; HUMANS; MALE; NEOPLASM METASTASIS; PARANEOPLASTIC POLYNEUROPATHY; PROSTATIC NEOPLASMS; SYNDROME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 2142717281     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3602.2002247     Document Type: Article

References (13)

1. Ramírez-Moreno JM, González-Dorrego F. Polirradiculoneuropatia desmielinizante inflamatoria crónica asociada a adenocarcinoma prostático. Rev Neurol 1999; 28: 394-6.
2. Martín-Araguz A. Neuropatías periféricas adquiridas. Medicine 1998; 7: 4554-64.
3. Rojas-Marcos I, Reñé-Ramírez R, Graus-Ribas F. Síndromes neurológicos paraneoplásicos. Medicine 1998; 7: 4528-32.
4. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuronopathy. Medicine (Baltimore) 1992; 71: 59-72.
5. Dropcho EJ. Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options. Ann Neurol 1995; 37 (Suppl 1): S102-13.
6. Graus F, Keime-Guibert F, Reñé R, Benyahia B, Ribalta T, Ascaso C, et al. Anti-Hu associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001; 124: 1138-48.
7. Forsyth PA, Dalmau J, Graus F, Cwik V, Rosenblum MK, Posner JB. Motor neuron syndromes in cancer patients. Ann Neurol 1997; 41: 722-30.
8. Antoine JC, Mosnier JF, Absi L, Convers P, Honnorat J, Michel D. Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies. J Neurol Neurosurg Psychiatry 1999; 67: 7-14.
9. Antoine JC, Honnorat J, Camdessanche JP, Magistris M, Absi L, Mosnier JF, et al. Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann Neurol 2001; 49: 214-21.
10. Molinuevo JL, Graus F, Cerrano C, Reñé R, Guerrero A, Ilia I. Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy. Ann Neurol 1998; 44: 976-80.
11. Anderson NE, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol 1988; 24: 559-67.
12. Vallderiola F, Vega F, Reñé R, Pou A, Roquer J, Graus F. Síndromes neurológicos asociados al anticuerpo anti-Hu. Estudio de 24 pacientes. Med Clin (Barc) 1992; 99: 361-4.
13. Humayun-Gultekin J, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000; 123: 1481-94.